LATANOPROST OPHTHALMIC SOLUTION 0.005%

LATANOPROST OPHTHALMIC SOLUTION 0.005% was reported 638 times

LATANOPROST OPHTHALMIC SOLUTION 0.005% is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EYE PROSTHESIS USER 1 0.0714
1 INSTILLATION SITE COMPLICATION 1 0.0476
2 EYELASH THICKENING 3 0.0250
3 TRICHOMEGALY 1 0.0227
4 TEAR DISCOLOURATION 1 0.0222
5 IRIS DISCOLOURATION 1 0.0217
6 ADMINISTRATION SITE RASH 2 0.0156
7 TICK-BORNE FEVER 1 0.0149
8 IRIS HYPERPIGMENTATION 3 0.0144
9 TRABECULECTOMY 1 0.0109
10 INTRAOCULAR PRESSURE FLUCTUATION 2 0.0102
11 BLEPHARAL PIGMENTATION 4 0.0079
12 PRODUCT CLOSURE REMOVAL DIFFICULT 8 0.0078
13 PRODUCT DROPPER ISSUE 6 0.0076
14 GROWTH OF EYELASHES 5 0.0063
15 GLARE 3 0.0058
16 EYELASH CHANGES 1 0.0056
17 SUPERFICIAL INJURY OF EYE 6 0.0055
18 FOREIGN BODY SENSATION IN EYES 31 0.0049
19 EYELASH DISCOLOURATION 1 0.0046
20 OPTIC DISC HAEMORRHAGE 1 0.0044
21 INTRAOCULAR PRESSURE INCREASED 55 0.0043
22 ORAL PUSTULE 1 0.0043
23 LARYNX IRRITATION 1 0.0043
24 INTRAOCULAR PRESSURE TEST ABNORMAL 3 0.0043
25 CORNEAL THINNING 1 0.0039
26 PRODUCT PACKAGING DIFFICULT TO OPEN 10 0.0038
27 CHEMICAL BURNS OF EYE 1 0.0036
28 EYELID PAIN 7 0.0034
29 EYELID MARGIN CRUSTING 9 0.0031
30 CONJUNCTIVITIS BACTERIAL 1 0.0029
31 PERIORBITAL IRRITATION 1 0.0029
32 LID SULCUS DEEPENED 1 0.0027
33 EYE IRRITATION 153 0.0027
34 PHYSICAL PRODUCT LABEL ISSUE 3 0.0025
35 INSTILLATION SITE PAIN 6 0.0024
36 INFUSION SITE DISCOLOURATION 2 0.0023
37 FACIAL NERVE DISORDER 1 0.0023
38 PRODUCT PACKAGE ASSOCIATED INJURY 5 0.0022
39 FOREIGN BODY IN EYE 2 0.0021
40 DARK CIRCLES UNDER EYES 3 0.0020
41 BLEPHARITIS 8 0.0020
42 EYELID IRRITATION 5 0.0020
43 CORNEAL SCAR 1 0.0020
44 EYE COLOUR CHANGE 2 0.0020
45 PRODUCT DEPOSIT 3 0.0019
46 EYE INFECTION BACTERIAL 1 0.0018
47 VULVOVAGINAL INJURY 1 0.0018
48 CORNEAL EPITHELIUM DEFECT 1 0.0017
49 HYPOAESTHESIA EYE 1 0.0017
50 ERYTHEMA OF EYELID 9 0.0017
51 PRODUCT CONTAINER ISSUE 14 0.0016
52 OPEN ANGLE GLAUCOMA 1 0.0016
53 EYELIDS PRURITUS 5 0.0016
54 EYE PAIN 87 0.0015
55 SCLERAL DISCOLOURATION 1 0.0015
56 HAND DERMATITIS 1 0.0014
57 PRODUCT EXPIRATION DATE ISSUE 2 0.0014
58 GLASSY EYES 1 0.0014
59 PRODUCT DESIGN ISSUE 1 0.0014
60 GRANULOMA ANNULARE 1 0.0014
61 INFUSION SITE INDURATION 2 0.0013
62 EYELID EXFOLIATION 1 0.0013
63 EYELID FUNCTION DISORDER 1 0.0013
64 OCULAR DISCOMFORT 14 0.0012
65 HYPOPYON 1 0.0012
66 OCULAR HYPERAEMIA 57 0.0012
67 PHOTOPHOBIA 22 0.0012
68 LIP PRURITUS 1 0.0012
69 ABNORMAL SENSATION IN EYE 5 0.0012
70 ASTHENOPIA 6 0.0011
71 EYE DISCHARGE 11 0.0011
72 CATARACT OPERATION 6 0.0010
73 NON-ALCOHOLIC STEATOHEPATITIS 1 0.0010
74 EYE PRURITUS 32 0.0010
75 EAR SWELLING 2 0.0009
76 INNER EAR DISORDER 1 0.0009
77 PRODUCT SELECTION ERROR 1 0.0009
78 CORNEAL DISORDER 2 0.0009
79 OCULAR TOXICITY 1 0.0009
80 PRODUCT LOT NUMBER ISSUE 2 0.0009
81 LACRIMATION INCREASED 27 0.0009
82 CORTISOL DECREASED 1 0.0009
83 EYELID OEDEMA 10 0.0009
84 SINUS PAIN 2 0.0009
85 MYOPIA 2 0.0008
86 MIGRAINE WITH AURA 2 0.0007
87 SKIN DEPIGMENTATION 1 0.0007
88 INCORRECT PRODUCT STORAGE 9 0.0007
89 EXCESSIVE EYE BLINKING 1 0.0007
90 CONJUNCTIVITIS ALLERGIC 1 0.0007
91 DRY EYE 33 0.0007
92 NEOPLASM SKIN 1 0.0006
93 NIGHT BLINDNESS 1 0.0006
94 INFUSION SITE HAEMORRHAGE 2 0.0006
95 PRODUCT LABEL ISSUE 4 0.0006
96 BLOOD CHLORIDE INCREASED 1 0.0006
97 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
98 CONJUNCTIVAL HYPERAEMIA 2 0.0006
99 NASAL OEDEMA 1 0.0006
100 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
101 PRODUCT PHYSICAL CONSISTENCY ISSUE 3 0.0005
102 WOUND HAEMORRHAGE 2 0.0005
103 CYSTOID MACULAR OEDEMA 1 0.0005
104 EYE INFLAMMATION 5 0.0005
105 RADIOTHERAPY 1 0.0005
106 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
107 TRIGEMINAL NEURALGIA 2 0.0005
108 EYE SWELLING 18 0.0005
109 HORDEOLUM 2 0.0005
110 VITREOUS DETACHMENT 1 0.0005
111 CORNEAL OEDEMA 1 0.0004
112 VISION BLURRED 61 0.0004
113 EYE INFECTION 5 0.0004
114 READING DISORDER 1 0.0004
115 ORAL PRURITUS 1 0.0004
116 HAEMANGIOMA 1 0.0004
117 WRONG DOSE 1 0.0004
118 EYE OEDEMA 1 0.0004
119 VITREOUS FLOATERS 4 0.0004
120 RETINAL TEAR 1 0.0004
121 VASODILATATION 1 0.0004
122 PRODUCT DELIVERY MECHANISM ISSUE 2 0.0004
123 ULCERATIVE KERATITIS 1 0.0004
124 MACULE 1 0.0004
125 MULTIPLE USE OF SINGLE-USE PRODUCT 2 0.0004
126 PERIORBITAL SWELLING 2 0.0004
127 TOOTH DISCOLOURATION 1 0.0003
128 OROPHARYNGEAL DISCOMFORT 3 0.0003
129 VARICES OESOPHAGEAL 1 0.0003
130 EYE INJURY 1 0.0003
131 PIGMENTATION DISORDER 2 0.0003
132 INFUSION SITE SWELLING 2 0.0003
133 PHOTOPSIA 2 0.0003
134 PRODUCT PACKAGING ISSUE 3 0.0003
135 OEDEMA MOUTH 1 0.0003
136 SKIN INJURY 1 0.0003
137 PRODUCT QUALITY ISSUE 39 0.0003
138 PRODUCT ODOUR ABNORMAL 3 0.0003
139 PRODUCT CONTAMINATION 1 0.0003
140 VISUAL FIELD DEFECT 2 0.0003
141 BLINDNESS TRANSIENT 2 0.0003
142 SUNBURN 2 0.0003
143 PARANASAL SINUS DISCOMFORT 1 0.0003
144 GLAUCOMA 5 0.0003
145 EPIGASTRIC DISCOMFORT 1 0.0003
146 SKIN PAPILLOMA 1 0.0002
147 PRODUCT PHYSICAL ISSUE 5 0.0002
148 APPLICATION SITE DISCOLOURATION 1 0.0002
149 HALLUCINATIONS, MIXED 1 0.0002
150 DEVICE OPERATIONAL ISSUE 1 0.0002
151 OCULAR ICTERUS 1 0.0002
152 VULVOVAGINAL DISCOMFORT 1 0.0002
153 INCORRECT DOSAGE ADMINISTERED 1 0.0002
154 PANCREATIC DISORDER 1 0.0002
155 STAPHYLOCOCCAL SEPSIS 1 0.0002
156 EYELID PTOSIS 2 0.0002
157 AMMONIA INCREASED 1 0.0002
158 EAR DISCOMFORT 2 0.0002
159 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
160 DIPLOPIA 5 0.0002
161 BODY HEIGHT DECREASED 2 0.0002
162 VISUAL IMPAIRMENT 23 0.0002
163 PRODUCT RESIDUE PRESENT 1 0.0002
164 SKIN ATROPHY 1 0.0002
165 EXTRA DOSE ADMINISTERED 7 0.0002
166 PRODUCT LABEL CONFUSION 1 0.0002
167 ENERGY INCREASED 1 0.0002
168 SINUS HEADACHE 1 0.0002
169 SYMPTOM RECURRENCE 1 0.0002
170 PLATELET COUNT ABNORMAL 1 0.0002
171 DRUG ADMINISTRATION ERROR 5 0.0002
172 MENISCUS INJURY 1 0.0002
173 NASAL DRYNESS 1 0.0002
174 BLEPHAROSPASM 1 0.0002
175 MYDRIASIS 2 0.0002
176 RHINORRHOEA 10 0.0002
177 CARDIAC FLUTTER 1 0.0002
178 PRODUCT DOSE OMISSION 10 0.0002
179 EYE HAEMORRHAGE 2 0.0001
180 PRODUCT STORAGE ERROR 13 0.0001
181 WRONG PRODUCT ADMINISTERED 1 0.0001
182 LIMB INJURY 4 0.0001
183 DEFAECATION URGENCY 1 0.0001
184 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
185 HEART RATE IRREGULAR 3 0.0001
186 SKIN DISCOLOURATION 6 0.0001
187 BRAIN FOG 2 0.0001
188 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
189 NASAL DISCOMFORT 1 0.0001
190 PRODUCT PRESCRIBING ERROR 3 0.0001
191 GINGIVAL PAIN 1 0.0001
192 BLINDNESS 5 0.0001
193 EYE DISORDER 4 0.0001
194 PRODUCT SUBSTITUTION ISSUE 7 0.0001
195 VISUAL ACUITY REDUCED 4 0.0001
196 SENSATION OF FOREIGN BODY 1 0.0001
197 INFUSION SITE ERYTHEMA 1 0.0001
198 PRODUCT COMPLAINT 3 0.0001
199 VITAMIN D DECREASED 1 0.0001
200 SKIN SWELLING 1 0.0001
201 BURNING SENSATION 8 0.0001
202 RESPIRATORY RATE INCREASED 1 0.0001
203 DRUG EFFECT INCOMPLETE 4 0.0001
204 LIP DRY 1 0.0001
205 RETINAL DETACHMENT 1 0.0001
206 INCREASED TENDENCY TO BRUISE 1 0.0001
207 IRON DEFICIENCY ANAEMIA 1 0.0001
208 PRODUCT DISTRIBUTION ISSUE 1 0.0001
209 CONJUNCTIVITIS 2 0.0001
210 NASAL CONGESTION 6 0.0001
211 INABILITY TO AFFORD MEDICATION 1 0.0001
212 DRY THROAT 1 0.0001
213 THERAPY INTERRUPTED 7 0.0001
214 THERAPY CESSATION 5 0.0001
215 VENTRICULAR EXTRASYSTOLES 1 0.0001
216 FOLLICULITIS 1 0.0001
217 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
218 SCRATCH 1 0.0001
219 DYSGEUSIA 7 0.0001
220 DECREASED ACTIVITY 1 0.0001
221 PRURITUS GENERALISED 2 0.0001
222 GASTROINTESTINAL PAIN 1 0.0001
223 EXPIRED PRODUCT ADMINISTERED 3 0.0001
224 SNEEZING 2 0.0001
225 IMPAIRED DRIVING ABILITY 1 0.0001
226 SCAB 1 0.0001
227 MADAROSIS 1 0.0001
228 MACULAR DEGENERATION 1 0.0001
229 BLOOD PRESSURE FLUCTUATION 2 0.0001
230 ACCIDENTAL OVERDOSE 3 0.0001
231 SPINAL OPERATION 1 0.0001
232 INJECTION SITE EXTRAVASATION 1 0.0001
233 HAIR COLOUR CHANGES 1 0.0001
234 AGEUSIA 2 0.0001
235 TOOTH INFECTION 1 0.0001
236 JOINT RANGE OF MOTION DECREASED 1 0.0001
237 FREQUENT BOWEL MOVEMENTS 2 0.0001
238 SINUS CONGESTION 1 0.0001
239 PRODUCT TASTE ABNORMAL 1 0.0001
240 TREATMENT NONCOMPLIANCE 4 0.0001
241 ORAL DISCOMFORT 1 0.0001
242 COORDINATION ABNORMAL 1 0.0001
243 SKIN REACTION 1 0.0001
244 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
245 PARAESTHESIA ORAL 1 0.0001
246 ANOSMIA 1 0.0001
247 CHEST DISCOMFORT 7 0.0001
248 IMMUNODEFICIENCY 1 0.0001
249 HAEMORRHAGE INTRACRANIAL 1 0.0001
250 UNEVALUABLE EVENT 5 0.0001
251 TINNITUS 3 0.0001
252 TENDONITIS 1 0.0001
253 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 13 0.0001
254 THERAPY PARTIAL RESPONDER 1 0.0001
255 PRODUCT USE COMPLAINT 1 0.0001
256 PRODUCTIVE COUGH 3 0.0001
257 CONDITION AGGRAVATED 19 0.0001
258 MUSCLE TIGHTNESS 1 0.0001
259 BLOOD POTASSIUM INCREASED 1 0.0001
260 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
261 COAGULOPATHY 1 0.0001
262 PALPITATIONS 7 0.0001
263 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
264 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
265 MUSCULOSKELETAL DISCOMFORT 1 0.0001
266 NIGHTMARE 2 0.0001
267 COLD SWEAT 1 0.0001
268 TOOTHACHE 1 0.0001
269 PELVIC PAIN 1 0.0001
270 DRUG DOSE OMISSION 9 0.0001
271 MIDDLE INSOMNIA 1 0.0001
272 HEPATIC CIRRHOSIS 1 0.0001
273 BLOOD SODIUM DECREASED 1 0.0001
274 FEELING JITTERY 1 0.0001
275 DRUG PRESCRIBING ERROR 1 0.0001
276 ERUCTATION 1 0.0001
277 EAR PAIN 1 0.0001
278 DYSPHONIA 3 0.0001
279 SINUS DISORDER 1 0.0001
280 CATARACT 3 0.0001
281 PRESCRIBED UNDERDOSE 1 0.0001
282 NO ADVERSE EVENT 9 0.0000
283 PRODUCT ADMINISTRATION ERROR 1 0.0000
284 DRY MOUTH 4 0.0000
285 ERYTHEMA 10 0.0000
286 DERMATITIS 1 0.0000
287 EATING DISORDER 1 0.0000
288 JOINT INJURY 1 0.0000
289 IMPAIRED WORK ABILITY 1 0.0000
290 BALANCE DISORDER 4 0.0000
291 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
292 PRODUCT DISPENSING ERROR 1 0.0000
293 INTENTIONAL PRODUCT MISUSE 4 0.0000
294 MELAENA 1 0.0000
295 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
296 THROAT IRRITATION 2 0.0000
297 PRODUCT AVAILABILITY ISSUE 1 0.0000
298 MUSCLE TWITCHING 1 0.0000
299 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
300 OROPHARYNGEAL PAIN 4 0.0000
301 SLEEP DISORDER 3 0.0000
302 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
303 SKIN BURNING SENSATION 3 0.0000
304 HEART RATE INCREASED 4 0.0000
305 HALLUCINATION 3 0.0000
306 SINUSITIS 4 0.0000
307 HEADACHE 24 0.0000
308 SKIN LESION 1 0.0000
309 ABNORMAL DREAMS 1 0.0000
310 MENTAL STATUS CHANGES 1 0.0000
311 WOUND 1 0.0000
312 BLISTER 2 0.0000
313 ASCITES 1 0.0000
314 BLOOD POTASSIUM DECREASED 1 0.0000
315 DISCOMFORT 2 0.0000
316 FEELING HOT 2 0.0000
317 NERVOUS SYSTEM DISORDER 1 0.0000
318 ATRIAL FIBRILLATION 3 0.0000
319 SWELLING FACE 2 0.0000
320 VIRAL INFECTION 1 0.0000
321 SKIN DISORDER 1 0.0000
322 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
323 DRUG INEFFECTIVE 39 0.0000
324 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
325 PRURITUS 11 0.0000
326 COUGH 8 0.0000
327 HEART RATE DECREASED 1 0.0000
328 MOBILITY DECREASED 2 0.0000
329 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
330 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
331 DYSPNOEA EXERTIONAL 1 0.0000
332 DIZZINESS 13 0.0000
333 ARTHRITIS 2 0.0000
334 DISORIENTATION 1 0.0000
335 JOINT SWELLING 3 0.0000
336 OSTEOPOROSIS 1 0.0000
337 INFLUENZA LIKE ILLNESS 2 0.0000
338 ROAD TRAFFIC ACCIDENT 1 0.0000
339 DRY SKIN 3 0.0000
340 COLITIS ULCERATIVE 1 0.0000
341 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
342 DEVICE ISSUE 2 0.0000
343 CHEST PAIN 4 0.0000
344 CARDIAC DISORDER 2 0.0000
345 PRODUCT USE ISSUE 4 0.0000
346 RASH ERYTHEMATOUS 1 0.0000
347 DYSPEPSIA 2 0.0000
348 FLUID RETENTION 1 0.0000
349 DYSPNOEA 11 0.0000
350 INFLAMMATION 1 0.0000
351 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
352 NERVOUSNESS 1 0.0000
353 BRADYCARDIA 1 0.0000
354 DRUG EFFECT DECREASED 1 0.0000
355 CONFUSIONAL STATE 3 0.0000
356 DISTURBANCE IN ATTENTION 1 0.0000
357 RASH 8 0.0000
358 MEDICATION ERROR 1 0.0000
359 INFLUENZA 2 0.0000
360 WEIGHT DECREASED 5 0.0000
361 PAIN 11 0.0000
362 NECK PAIN 1 0.0000
363 OXYGEN SATURATION DECREASED 1 0.0000
364 ASTHMA 2 0.0000
365 MYALGIA 3 0.0000
366 INCORRECT DOSE ADMINISTERED 4 0.0000
367 HERPES ZOSTER 1 0.0000
368 LETHARGY 1 0.0000
369 COVID-19 3 0.0000
370 BONE PAIN 1 0.0000
371 PRODUCT DOSE OMISSION ISSUE 5 0.0000
372 WHEEZING 1 0.0000
373 FEELING ABNORMAL 4 0.0000
374 VERTIGO 1 0.0000
375 MUSCLE SPASMS 3 0.0000
376 HYPERSENSITIVITY 3 0.0000
377 ALOPECIA 3 0.0000
378 NAUSEA 12 0.0000
379 BLOOD PRESSURE DECREASED 1 0.0000
380 INSOMNIA 4 0.0000
381 HEPATIC ENZYME INCREASED 1 0.0000
382 EPISTAXIS 1 0.0000
383 HYPOAESTHESIA 2 0.0000
384 DEPRESSION 3 0.0000
385 DIABETES MELLITUS 1 0.0000
386 BLOOD PRESSURE INCREASED 2 0.0000
387 DECREASED APPETITE 3 0.0000
388 INJECTION SITE BRUISING 1 0.0000
389 PROSTATE CANCER 1 0.0000
390 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
391 ABDOMINAL DISCOMFORT 2 0.0000
392 URINARY TRACT INFECTION 2 0.0000
393 GASTROINTESTINAL DISORDER 1 0.0000
394 ADVERSE DRUG REACTION 1 0.0000
395 NASOPHARYNGITIS 2 0.0000
396 DYSPHAGIA 1 0.0000
397 PULMONARY EMBOLISM 1 0.0000
398 MIGRAINE 1 0.0000
399 DRUG INTOLERANCE 1 0.0000
400 SYNCOPE 1 0.0000
401 HYPOTENSION 2 0.0000
402 SOMNOLENCE 2 0.0000
403 ILLNESS 1 0.0000
404 ARTHRALGIA 4 0.0000
405 HAEMORRHAGE 1 0.0000
406 HYPERTENSION 2 0.0000
407 DIARRHOEA 6 0.0000
408 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
409 FATIGUE 7 0.0000
410 MUSCULAR WEAKNESS 1 0.0000
411 SEIZURE 1 0.0000
412 BACK PAIN 2 0.0000
413 CHILLS 1 0.0000
414 DISEASE PROGRESSION 1 0.0000
415 INJECTION SITE ERYTHEMA 1 0.0000
416 MEMORY IMPAIRMENT 1 0.0000
417 MALAISE 3 0.0000
418 HOSPITALISATION 1 0.0000
419 PERIPHERAL SWELLING 1 0.0000
420 VOMITING 3 0.0000
421 DRUG INTERACTION 1 0.0000
422 PNEUMONIA 2 0.0000
423 TREMOR 1 0.0000
424 URTICARIA 1 0.0000
425 CEREBROVASCULAR ACCIDENT 1 0.0000
426 PYREXIA 2 0.0000
427 ASTHENIA 2 0.0000
428 BLOOD GLUCOSE INCREASED 1 0.0000
429 GAIT DISTURBANCE 1 0.0000
430 CONSTIPATION 1 0.0000
431 OFF LABEL USE 4 0.0000
432 WEIGHT INCREASED 1 0.0000
433 ABDOMINAL PAIN 1 0.0000
434 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
435 ANXIETY 1 0.0000
436 PAIN IN EXTREMITY 1 0.0000
437 INJECTION SITE PAIN 1 0.0000
438 FALL 1 0.0000